Global 6'-Sialyllactose (6'-SL) Market Strategic Research Report

Scope of the Report

The global 6'-Sialyllactose (6'-SL) market size is predicted to grow from US$ 119 million in 2025 to US$ 345 million in 2032; it is expected to grow at a CAGR of 16.9% from 2026 to 2032.

In 2025, global 6'-Sialyllactose production reached approximately 642 tons, with an average global market price of around US$190 per kilogram. 6'-Sialyllactose (6'-SL) is a purified, white to off-white powder or agglomerates that is produced by a microbial process and contains limited levels of lactose and sialic acid. 6′-SL is the most abundant sialylated HMO in human milk.

6'-Sialyllactose (6'-SL) is a key sialylated human milk oligosaccharide (HMO) found in human milk, playing an important role in infant immune regulation and brain development. With the maturation of HMO synthesis technologies and regulatory progress across countries (such as approvals in China and GRAS recognition in the United States), the 6'-SL market is experiencing rapid growth in infant formula and functional food applications. With the industrialization of precision fermentation, this molecule, defined by its unique α2,6-linkage, has become the decisive factor in the premiumization of infant formula. Its biological activity premium in neurological development and immune modulation is driving global dairy leaders to re-prioritize their supply chain strategies. The accelerated approval of 6'-SL as a novel food ingredient by various regulatory bodies has not only mitigated compliance risks for multinational trade but also signals an evolution in breast milk mimicry from quantitative approximation to structural identity. Nevertheless, the rigorous requirements for enzymatic conversion efficiency and distillation purity during production form a natural technological moat, resulting in a highly concentrated supply landscape. The current strategic focus has shifted from mere volume expansion to the continuous iteration of biomanufacturing processes. The goal is to maintain pharmaceutical-grade purity while lowering the entry barriers for application across the entire human life cycle, thereby unlocking new blue-ocean growth opportunities beyond early-life nutrition.

Key Questions Addressed in this Report

What is the 10-year outlook for the global 6'-Sialyllactose (6'-SL) market?

What factors are driving 6'-Sialyllactose (6'-SL) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do 6'-Sialyllactose (6'-SL) market opportunities vary by end market size?

How does 6'-Sialyllactose (6'-SL) break out by Type, by Application?

This report presents a comprehensive overview of the global 6'-Sialyllactose (6'-SL) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Microbial Fermentation
• Enzymatic Synthesis

Segment by Assay

• Assay ≥80%
• Assay ≥90%

Segment by Grade

• Food Grade
• Research Grade

Segment by Application

• Infant Formula
• Food
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global 6'-Sialyllactose (6'-SL) market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Infant Formula, Food, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact